Holen Sie sich die Stockscreener-App
4.49
4.26%
-0.20
Vorhandelsmarkt:
4.49
Aurora Cannabis Inc. Aktie (ACB) Neueste Nachrichten
(ACB) Pivots Trading Plans and Risk Controls (ACB:CA) - news.stocktradersdaily.com
Aurora Cannabis Inc. (TSE:ACB) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny - simplywall.st
Aurora Cannabis Announces Shareholder Meeting Details - The Globe and Mail
Aurora Cannabis announces annual shareholder meeting details - Investing.com
Aurora Cannabis Inc. Announces Filing and Mailing of the Managem - GuruFocus
Aurora Cannabis files shareholder meeting materials ahead of august vote - StreetInsider
Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General and Special Meeting of Shareholders - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurora Cannabis Inc.ACB - PR Newswire
Aurora Expands Patient Access to Medical Cannabis in Canada with Extended Compassionate Pricing Program - PR Newswire
Premium 29% THC Medical Cannabis: Aurora Breaks Potency Records in Polish Market Launch - Stock Titan
Aurora Cannabis Inc. (NASDAQ:ACB) Q4 2025 Earnings Call Transcript - Insider Monkey
Aurora Cannabis says there is no truth to articles written with AI and published on investing site - The Globe and Mail
Aurora Cannabis Inc (ACB) (Q4 2025) Earnings Call Highlights: Re - GuruFocus
Aurora Cannabis Reports Record Revenue and Growth - TipRanks
Aurora Cannabis denies news of acquisition of New Zealand’s Medleaf Therapeutics - StratCann
Aurora Cannabis Refutes MedLeaf Acquisition Rumors - mg Magazine
Aurora Cannabis announces new strategic partnership - Investing.com
Aurora Cannabis (ACB) Denies Acquisition of MedLeaf Therapeutics - GuruFocus
Aurora Cannabis Denies Acquisition Rumors of MedLeaf Therapeutics - TipRanks
Aurora Cannabis denies acquisition of MedLeaf Therapeutics - Investing.com
Aurora Cannabis (ACB) Refutes Acquisition Rumors of MedLeaf Therapeutics | ACB Stock News - GuruFocus
Aurora Cannabis Denies News of Acquisition of MedLeaf Therapeutics | ACB Stock News - GuruFocus
Aurora Cannabis (ACB) Denies News of Acquisition of MedLeaf Therapeutics - StreetInsider
Aurora Cannabis Denies News Of Acquisition Of MedLeaf Therapeutics - Barchart.com
Cannabis Stock Movers For June 18, 2025 - Benzinga
EXCLUSIVE: Medical Cannabis Is Growing And Profitable, Says Aurora CEO — Investors Are Just Missing The Story - Benzinga
Aurora Cannabis Q4 2025 Earnings Call Transcript - MarketBeat
Aurora Cannabis: Poland Headwinds Result In Disappointing Outlook (Rating Downgrade) (ACB) - Seeking Alpha
Aurora Cannabis CEO touts ‘pristine’ balance sheet, but shares tumble - BNN Bloomberg
Aurora Cannabis pays $215 million to acquire MedLeaf Therapeutics - MJBizDaily
Aurora Cannabis announces strategic acquisition of MedLeaf Therapeutics By Investing.com - Investing.com India
Aurora Cannabis announces strategic acquisition of MedLeaf Therapeutics - Investing.com
Canadian Medical Marijuana Firm Aurora Cannabis Expects Weak Demand In International Market - Benzinga
Aurora Cannabis Stock Falls as Canadian Producer Expects International Sales to Decline - MSN
Aurora Cannabis (ACB) Reports Significant Q4 Revenue Growth - GuruFocus
Aurora Cannabis Inc. - Baystreet.ca
Aurora Cannabis (ACB) Shares Tumble After Earnings Report | ACB Stock News - GuruFocus
Aurora Cannabis (ACB) Shares Drop Despite Exceeding Revenue Expe - GuruFocus
Aurora Cannabis Inc. (ACB) Misses Q4 Earnings Estimates - Yahoo Finance
Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Aurora Cannabis drops despite Q4 beat amid concerns over international growth - MSN
Aurora Cannabis (NASDAQ:ACB) Posts Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat
Aurora Cannabis Achieves Record Revenue and EBITDA in Fiscal 2025 - TipRanks
Aurora Cannabis (ACB) Eyes First Profitable Year Amid Sector Cha - GuruFocus
Aurora Cannabis Files Full Year Results and Announces Fiscal 2025 Fourth Quarter - Placera.se
Aurora Cannabis Q4 Loss Narrows, Adj.EBITDA Surges; Sees Sequentially Weak Demand In Q1; Stock Drops - Nasdaq
ACB Projects Slight Dip in Q1 Revenue with Positive Cash Flow Ou - GuruFocus
Aurora Cannabis Q4 FY25 slides: positive cash flow achieved amid global expansion - Investing.com
Aurora Cannabis Files Full Year Results and Announces Fiscal 202 - GuruFocus
Aurora Cannabis (ACB) Reports Strong Q4 Adjusted EBITDA Growth | ACB Stock News - GuruFocus
ACB in charts: Q4 revenue from medical cannabis, plant propagation climb, consumer segment down - Seeking Alpha
Aurora Cannabis Files Full Year Results And Announces Fiscal 2025 Fourth Quarter - Barchart.com
Germany Legal Cannabis Market Report 2025-2030: Competitive - GlobeNewswire
Aurora Cannabis (ACB) Prepares for Earnings Announcement - GuruFocus
GMS, Korn/Ferry, Aurora Cannabis to report earnings Wednesday By Investing.com - Investing.com Nigeria
GMS, Korn/Ferry, Aurora Cannabis to report earnings Wednesday - Investing.com
Cannabis Hyperemesis Syndrome Class Action Certified - mg Magazine
Aurora Cannabis Faces Class Action Over Lack of Warnings About Cannabinoid Hyperemesis Syndrome - Cannabis Health News
What To Expect From Aurora Cannabis Inc (TSX:ACB) Q4 2025 Earnings - Yahoo Finance
Aurora Cannabis: Poised For Its First Profitable Year (NASDAQ:ACB) - Seeking Alpha
Is Aurora Cannabis (ACB) a Good Stock to Buy before Earnings? - TipRanks
Earnings week ahead: KR, ACN, ACB, and more (NASDAQ:ACB) - Seeking Alpha
Aurora Cannabis (ACB) Projected to Post Earnings on Wednesday - MarketBeat
Cannabis Stock CGC Rallies 39% in Three Months: Time to Buy or Sell? - The Globe and Mail
Aurora Cannabis Requests to Dismiss Class Action Filed by Investors - TradingView
Aurora Cannabis Inc. stock rises Wednesday, outperforms market - MarketWatch
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):